Evaluation of the RABBIT Risk Score for serious infections

Ítems similars

• Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
  per: Meissner, Y, et al.
  Publicat: (2017)
• Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
  per: Richter, A, et al.
  Publicat: (2016)
• Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
  per: Strangfeld, A, et al.
  Publicat: (2011)
• Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
  per: Listing, Joachim, et al.
  Publicat: (2015)
• Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
  per: Strangfeld, A, et al.
  Publicat: (2017)